Paper769946
Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.
Gross NJ and 1 other. Cancer, 1976. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease. Papers, record 769946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/769946
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Immunotherapy | Major topic |
| Lung Neoplasms | Major topic |
| Melanoma | Major topic |
| Mycobacterium bovis | Major topic |
| Humans | |
| Lectins | |
| Lymphocyte Activation | |
| Prognosis | |
| Skin Tests | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7093814 | Cell mediated immune response in miniature Sinclair swine bearing cutaneous melanomas. | Can J Comp Med | 1982 | https://conductscience.org/library/papers/7093814 | PubMed |
| 6352007 | Serial immune function testing to predict clinical disease relapse in patients with solid tumors. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6352007 | PubMed |
| 3719596 | Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3719596 | PubMed |
| 732053 | Immunological responsiveness and adjunct immunotherapy in lung cancer. | Jpn J Surg | 1978 | https://conductscience.org/library/papers/732053 | PubMed |
| 487647 | Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/487647 | PubMed |
| 442002 | Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG. | Thorax | 1979 | https://conductscience.org/library/papers/442002 | PubMed |
| 428146 | Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/428146 | PubMed |
| 358479 | Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial). | Thorax | 1978 | https://conductscience.org/library/papers/358479 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/769946
GET https://conductscience.org/api/papers/v1/769946/authors